Paule Opolon
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
DiPRO1 distinctly reprograms muscle and mesenchymal cancer cells.
Journal: EMBO molecular medicine
Published: January 10, 2023
Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer.
Journal: Journal for immunotherapy of cancer
Published: January 08, 2022
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.
Journal: Cancer discovery
Published: July 25, 2021
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Journal: Nature medicine
Published: December 01, 2020
Autophagy-mediated metabolic effects of aspirin.
Journal: Cell death discovery
Published: September 01, 2020
Ileal immune tonus is a prognosis marker of proximal colon cancer in mice and patients.
Journal: Cell death and differentiation
Published: August 06, 2020
Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
Journal: The Journal of experimental medicine
Published: April 30, 2020
Chemical activation of SAT1 corrects diet-induced metabolic syndrome.
Journal: Cell death and differentiation
Published: March 05, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer.
Journal: Nature medicine
Published: August 28, 2019
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade.
Journal: Cell research
Published: March 05, 2019
Last Updated: 09/26/2026